ACLS EP cardiac1

download ACLS EP cardiac1

of 48

Transcript of ACLS EP cardiac1

  • 7/27/2019 ACLS EP cardiac1

    1/48

    1

    Learning Station 1

    CardiovascularEmergencies Case 11999 American Heart Association

  • 7/27/2019 ACLS EP cardiac1

    2/48

    2

    Acknowledgments

    Janice Ritchie Saia, RN, EMT-P, of St. Petersburg,

    FL, first developed these materials. She has

    generously donated her work to the AHA. Steve Anderson, MD, of Auburn, WA, provided

    helpful scripts for this case.

    Mary Fran Hazinski, RN, MSN, and John Field, MD,

    provided many refinements during final review. We

    appreciate the hard work of each of these people.

    2

  • 7/27/2019 ACLS EP cardiac1

    3/48

    3

    Learning Objectives

    Apply the Five Quadrads Approach to patients withcomplex cardiovascular emergencies

    Discuss, assess, and manage acute MI

    Identify ECG changes consistent with

    Myocardial ischemia/infarction

    Location of infarct

    Infarct-related coronary artery

    After completing this learning station you should beable to

  • 7/27/2019 ACLS EP cardiac1

    4/48

    4

    Case History

    Mr. B. Skimmer, age 45, complains of chest

    discomfort, nausea, severe fatigue

    Past Med Hx: hypertension (poor control),

    2 to 3 pack/day cigarettes, high stress job

    Refuses coworkers assistance

    States: Its just the flu

    Goes to break room to rest

  • 7/27/2019 ACLS EP cardiac1

    5/48

    5

    Case Progression

    One hour later a coworker finds Mr. Skimmer

    lethargic, pale, profusely diaphoretic

    Coworker offers to drive Mr. Skimmer to ED,

    only 3 minutes away

    Should M r. Skimmer go to ED byALS ambulance?

    WHY?

  • 7/27/2019 ACLS EP cardiac1

    6/48

    6

    Case Progression

    Mr. Skimmer arrives at your ED with O2

    via NRB; IV LR @ KVO

    Received MONA in field; BP dropped

    alarmingly, near syncope

    Triaged as urgent

    Placed in ED critical care bed

    What should youas the key

    ACLS providerdo first?

  • 7/27/2019 ACLS EP cardiac1

    7/487

    The Five Quadrads Approachto ACLS-EP

    1. Primary ABCD Survey

    2. Secondary ABCD Survey

    3. OxygenIVmonitorfluids

    4. TempBPHRRR

    5. Tanktankpumprate

  • 7/27/2019 ACLS EP cardiac1

    8/488

    AssessmentF ive Quadrads Approach

    Primary Survey

    Airway: adequate

    Breathing: present with equal chest rise,

    adequate tidal volume

    Circulation: pulse present carotid and

    radial

    Defibrillation: not needed

  • 7/27/2019 ACLS EP cardiac1

    9/48

    9

    Secondary Survey

    Airway: adequate

    Breathing: lung sounds clearOxygen sat 97% with NRB

    Circulation: sinus rhythm

    2-mm ST-elevation in leads II, III, aVF

    BP 126/84 mm Hg; IV access present

    Differential diagnosis: AMI. Others?

    AssessmentF ive Quadrads Approach

  • 7/27/2019 ACLS EP cardiac1

    10/48

    10

    OxygenIVmonitorfluids

    Started by EMS; continued in ED

    Vital signs

    T=99.1F, BP=126/84 mm Hg,HR=74 bpm, RR=28/min

    Tanktankpumprate Consider sources of hemodynamic

    compromise

    AssessmentF ive Quadrads Approach

  • 7/27/2019 ACLS EP cardiac1

    11/48

    11

    What would you like to doNOW?

  • 7/27/2019 ACLS EP cardiac1

    12/48

    12

    Immediate ED Assessments

    O2IVmonitorfluids (done by EMS)

    Grade chest pain: character, intensity

    H & P: focus on thrombolytic screening

    VSfrequent recordings

    Multilead ECG? (12, 15, or 22 leads)

    First set serum markers Electrolytes; coagulation studies

    Portable chest film

  • 7/27/2019 ACLS EP cardiac1

    13/48

    13

    12-Lead ECG Findings

    1. ST-segment

    elevationor new LBBB

    strongly suspicious

    for injury

    2. ST-segment

    depression/dynamicT-wave inversion;

    strongly suspicious

    for ischemia

    3. Nondiagnostic

    or normal ECG;chest pain strongly

    suspicious for

    ischemia

  • 7/27/2019 ACLS EP cardiac1

    14/48

    14

    Localizing Ischemia or Injury

    aVF inferiorIII inferior V3 anterior V6 lateral

    aVL lateralII inferior V2 septal V5 lateral

    aVRI lateral V1 septal V4 anterior

  • 7/27/2019 ACLS EP cardiac1

    15/48

    15

    ECG 1: Interpretation?

  • 7/27/2019 ACLS EP cardiac1

    16/48

    16

    ECG 1: elevated ST segments; inferior leads (II, III, aVF);ST depression: precordial leads V2-V5; lateral leads I, aVL

    Suspect occlusionr ight coronary artery

  • 7/27/2019 ACLS EP cardiac1

    17/48

    17

    Coronary Artery Distribution

    Left

    Septal wall of LV

    Anterior and lateral

    walls of LV

    Inferior wall LV

    (10%)

    Both bundle branches

    Right

    Inferior wall of LV

    Posterior wall of

    LV (90%)

    AV node (90%)

    Right ventricle

  • 7/27/2019 ACLS EP cardiac1

    18/48

    18

    Cardiac Anatomy in Relationto Coronary Artery

    Rightcoronary

    artery

    Septal wallV1-V2

    Left anteriordescending artery

    Anterior wallV3-V4

    Left main

    coronaryartery

    Circumflexartery

    Lateral wallI, aVL, V5-V6

  • 7/27/2019 ACLS EP cardiac1

    19/48

    19

    NOTE 1: Inferior wallsupplied by either the right

    (85% to 90% of people) or

    left coronary artery.

    NOTE 2: If there is acute

    injury in inferior leads(II, III, aVF), unknown

    whether left or right

    coronary artery is blocked.

    NOTE 3: KEYyou

    must obtain a RIGHT-SIDED ECG at once.

    Posterior View of the Heart

    HOW TO GET

    RIGHT-SIDED ECG?

    Leads II, III, aVF

    (from leftcoronaryartery)

    Lateral wall

    Inferior wall

    Right coronaryartery

    Posteriordescending

    artery

    Posteriorwall

    Circumflexartery

  • 7/27/2019 ACLS EP cardiac1

    20/48

    20

    Lead Placement for aRight-sided ECG

    V1

    V3R

    V4RV5

    RV6R

    V2

  • 7/27/2019 ACLS EP cardiac1

    21/48

    21

    Right Ventricular Infarction

    Inferior lead changes RV infarction?

    Use lead V4R (ST elevation >1 mm)

    Clinical significance:

    Increased mortality

    Preload dependence

    Vasodilators may cause severe hypotension

    What is management of RV infarction?

  • 7/27/2019 ACLS EP cardiac1

    22/48

    22

    How would you managethis patient?

  • 7/27/2019 ACLS EP cardiac1

    23/48

  • 7/27/2019 ACLS EP cardiac1

    24/48

    24

    Nitroglycerin

    Mechanism of action

    Indications

    Administration

    Cautions

  • 7/27/2019 ACLS EP cardiac1

    25/48

    25

    Narcotic Analgesia

    Morphine sulfatereadily available

    Effects

    Relieves pain and anxiety Reduces myocardial oxygen needs

    Administration

    2 to 5 mg IV q 5 minutes (slow) Caution

    N & V, low BP, respiratory depression

  • 7/27/2019 ACLS EP cardiac1

    26/48

    26

    Aspirin

    Aspirin inhibits platelet cyclo-oxygenase

    decreases thromboxane A2 production

    Aspirin benefits

    Reduces overall mortality in AMI

    Reduces incidence of nonfatal reinfarction

    Dose: 160 to 325 mg PO ASAP

  • 7/27/2019 ACLS EP cardiac1

    27/48

    27

    -BlockersMechanism of action

    Block catecholamines from binding to

    -adrenergic receptors

    Nonselective and cardioselective

    Reduce HR, BP, myocardial

    contractility, and oxygen consumption

    Decrease AV nodal conduction

  • 7/27/2019 ACLS EP cardiac1

    28/48

    28

    -Blockers

    Severe CHF/PE Hypotension

    (SBP

  • 7/27/2019 ACLS EP cardiac1

    29/48

    29

    Heparin

    Mechanism of action

    Indirect thrombin inhibitor (with AT III)

    Indications

    PTCA or CABG

    With fibrin-specific lytics (eg, alteplase)

    High risk for systemic emboli Large anterior MI, atrial fib, LV thrombus

  • 7/27/2019 ACLS EP cardiac1

    30/48

    30

    ACE Inhibitors

    Mechanism of action

    Lower BP by inhibiting angiotensin-

    converting enzyme (ACE) Attenuate LV remodeling by inhibiting

    tissue ACE

    Lower peripheral vascular resistance byvasodilatation mechanism

    Reduce mortality from AMI

    P t i d

  • 7/27/2019 ACLS EP cardiac1

    31/48

    31

    Potassium andMagnesium Sulfate

    Potassium deficiency but not magnesium

    deficiency associated with arrhythmias,

    sudden death Recent studies suggest no reduction in AMI

    mortality with magnesium administration

  • 7/27/2019 ACLS EP cardiac1

    32/48

    32

    I s M r. Skimmer a candidate for

    thrombolysis?

    What information do you need to

    make this decision?

    Case Progression

    C t i di ti t

  • 7/27/2019 ACLS EP cardiac1

    33/48

    33

    Contraindications toThrombolytic Therapy

    Previous hemorrhagicstroke any time

    Other stroke, CVAwithin 1 year; ICneoplasm

    Active internal bleeding(not menses)

    Suspected aorticdissection

    Severe uncontrolledhypertension (>180/110)

    Current use ofanticoagulants

    Recent trauma (2 to 4 wk);major surgery

  • 7/27/2019 ACLS EP cardiac1

    34/48

    34

    Percutaneous TransluminalCoronary Angioplasty

    Direct treatment

    Mechanical reperfusion of infarct-related

    coronary artery

    Best outcome achieved for patients with AMI

    plus cardiogenic shock

  • 7/27/2019 ACLS EP cardiac1

    35/48

    35

    Case Progression

    Mr. Skimmer received oxygen, aspirin,

    metoprolol IV, and heparin

    No nitroglycerin or morphine in ED

    Now pain-free; stable BP; O2 sat 98%

    Reperfusion therapy: t-PA + heparin

  • 7/27/2019 ACLS EP cardiac1

    36/48

    36

    ECG 2: Interpretation?

  • 7/27/2019 ACLS EP cardiac1

    37/48

    37

    Case Progression

    Mr. Skimmer transferred to CCU

    Uneventful night

    No chest pain or shortness of breathNo arrhythmias

    Treatment:

    Oxygen at 2 L/min Heparin, ACE inhibitors, -blockers

    Nitroglycerin not given

  • 7/27/2019 ACLS EP cardiac1

    38/48

    38

    The next day

    In CCU Mr. Skimmer begins complaining of

    Chest pressure

    Light-headedness

    Increasing intensity over 20 minutes

    What should you do now?

  • 7/27/2019 ACLS EP cardiac1

    39/48

    39

    The Five Quadrads

    Primary Survey: no CPR or defibrillation indicated

    Secondary Survey

    Airway: adequate Breathing: dyspnea, + JVD, rales in lower third

    of lung fields

    Circulation: diaphoretic; peripheralpulses weak

    Differential diagnosis: obtain 12-lead ECG

  • 7/27/2019 ACLS EP cardiac1

    40/48

    40

    The Five Quadrads

    OxygenIVmonitorfluids

    Vital signs

    BP 76/64 mm Hg, HR 80 bpm, RR 32/min

    Tanktankpumprate

    What is the nature of the problem?

    Check 12-lead ECG

  • 7/27/2019 ACLS EP cardiac1

    41/48

    41

    ECG 3: Interpretation?

    SR with ST-segment elevation in leads II, III,

    aVF; reciprocal changes throughout

    T t t C id ti

  • 7/27/2019 ACLS EP cardiac1

    42/48

    42

    Treatment ConsiderationsAcute Pulmonary Edema With Hypotension

    Oxygen

    Furosemide Avoid, if possible,

    nitroglycerin or

    morphine, especially if

    patient is hypotensive

    Dopamine

    Dobutamine PEEP (caution)

    CPAP

    First-line Actions Second-line Actions

  • 7/27/2019 ACLS EP cardiac1

    43/48

    43

    Treatment Considerations

    Priority actions

    Thrombolytic therapy (repeat t-PA)

    Coronary angiography and angioplasty or

    emergency surgical revascularization

    Intra-aortic balloon pump

  • 7/27/2019 ACLS EP cardiac1

    44/48

    44

    Differential Diagnosis

    Reocclusion RCA; infarct extension

    Mechanical complications (eg, mitral

    regurgitation, VSD)

    Low cardiac output

    Pulmonary embolus

  • 7/27/2019 ACLS EP cardiac1

    45/48

    45

    Case Progression

    Pulmonary edema persists

    Cardiogenic shock continues

    Patient remains hypotensive

    ECG: ST elevation consistent with reocclusion

    Strategy: coronary angiography

    Outcome: angioplasty and stent proximal RCA

  • 7/27/2019 ACLS EP cardiac1

    46/48

    46

    Summary

    Five Quadrads Layered approach; guides actions and thinking

    Apply whenever you arrive at an emergency setting Goals of coronary syndrome treatment

    Early reperfusion therapy (myocardial salvage) whenindicated

    Reduce morbidity and mortality through adjunctive agents(ASA, -blockers, ACE, statins)

    Recognize and anticipate serious early complications:unstable post-MI angina, CHF, late VT/VF

  • 7/27/2019 ACLS EP cardiac1

    47/48

    47

    Summary

    A focused history and assessment facilitates

    early initiation of reperfusion therapy

    The 12-lead ECG may be used to localizeinjury and guide therapy

    Serum markers may be used to triage patients

    and assess prognosis

  • 7/27/2019 ACLS EP cardiac1

    48/48

    Summary

    Several treatments help patients by

    Decreasing mortality

    Limiting extent of infarction Limiting incidence of reinfarction

    Knowledge of complicated AMIs enables us to

    Anticipate complications Care for patients with complex acute coronary

    syndromes